MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.
about
Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinomaPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesMicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma.Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse modelAssociation of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation.Case report evidence of relationships between hepatocellular carcinoma and ochratoxicosis.Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model.Predicting tissue specific transcription factor binding sites.MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA.HBx induced AFP receptor expressed to activate PI3K/AKT signal to promote expression of Src in liver cells and hepatoma cellsPathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Stem cells in liver diseases and cancer: recent advances on the path to new therapies.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine.ROCK inhibition enhances microRNA function by promoting deadenylation of targeted mRNAs via increasing PAIP2 expressionCirculating tumor cells measurements in hepatocellular carcinoma.Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.ZBTB20 is a sequence-specific transcriptional repressor of alpha-fetoprotein geneImpact of CUX2 on the female mouse liver transcriptome: activation of female-biased genes and repression of male-biased genes.Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7.Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring.Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.Novel insights into the molecular mechanisms of α-fetoprotein expression and malignant phenotypes of hepatocellular carcinomaThe mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC).The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.Antitumor function of microRNA-122 against hepatocellular carcinoma.The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma.Significant biomarkers for the management of hepatocellular carcinoma.MicroRNA-122 regulates polyploidization in the murine liver.Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA.Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs.New Insights into the Epigenetics of Hepatocellular Carcinoma.Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice.
P2860
Q27026846-A5C65B85-5258-41C9-AF56-0E55FB568020Q28272678-0A8796E2-940A-4F4C-95D4-D22D0032FE8AQ30439971-C886A466-65F6-4620-A712-0C444E5F0111Q34026072-D1D50E3F-5F44-4BD9-89A1-6CD53BAFCF62Q34038257-885D010B-C072-4510-9F58-0E766C0B6569Q34282931-632D6352-7DD9-413A-9165-1CA7D9012712Q34294469-E5AC754A-5624-45CB-BF65-CA998238CB6BQ34298155-C7847041-E251-4BA5-8BF6-D6C1B1B3751EQ34971134-0E96F0F0-7A3B-47D7-9F75-73F2F79EE4C7Q34983857-AAB9B02C-8F18-44C4-974C-53030BE5B186Q35044479-27B6DE5A-5DFC-48D8-ABF7-C82572993832Q35200832-E8DD3CF7-AC3C-4107-A8B8-9396333C6CB1Q35595069-2095CDE1-7319-42E1-8A09-AB8A879AEB4DQ35619104-7A67D04D-FE7D-4F6A-85AC-634658800B09Q35631841-43217A38-5B3B-425D-90E8-1D4DE31F33F9Q35715931-EB4CF082-DC98-4331-A0EE-5085C08688D3Q35781589-BEF20D38-49CE-432B-984A-C1F4706091A3Q36002513-A1E8F4EE-3E5C-4021-805D-345E9D6ACA63Q36011412-E8EC8ED8-4C2E-43A4-BF2A-5C5EB6DB56CAQ36129129-8E7E5B59-6B0E-4D9A-BCC1-DF2CFAFF14ECQ36288638-0D945889-948A-403B-81BF-5F2DA5FCBEB3Q36362912-6E958FD2-29AD-4165-A010-C94DABD58363Q36691039-17D069DE-AD92-4017-B027-FDB61525A032Q37534945-A7B5465C-3082-49A8-BF8E-F16C6A0704EDQ37644875-B9E886A2-4014-45DA-83A7-F63FD7FF62C8Q37729138-DF8D2165-353B-4355-8510-55EB63D0C2F0Q37747422-5B92B316-2A51-4546-8D51-6335F25FD769Q37943714-67FDE930-5DC8-454C-89D9-459D55A0FE48Q38164571-CDA32223-64ED-41B6-9C94-21598E077937Q38188460-997EACEE-C475-453E-81DD-09284544C784Q38213933-7DD101BD-F9F8-4644-8D49-0D195F3EAF48Q38334014-E6459429-37FD-4CB4-8C29-47E0FDAFD3C7Q38412315-55464449-A45E-42D1-A734-712EA9EBB81EQ38890010-03F0336A-271D-4C3E-8FCD-D5B8A24FA789Q38975168-671BE0E6-E372-4FDF-9EF7-4C11FF27A5BCQ38989340-C5BE4483-EC70-472C-95E9-3AA10ABD73E4Q39092681-EE0AC53C-7630-4C69-A0A6-F3A95585BB41Q41990459-CC987E9C-C705-4F7F-B9C5-9A117D46B676Q42255569-D9622823-F586-4F48-A319-F9C9A7173405Q42576894-94B50464-E4C4-432E-BE64-69E815DA2896
P2860
MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MicroRNA122 is a key regulator ...... s of hepatocellular carcinoma.
@en
MicroRNA122 is a key regulator ...... s of hepatocellular carcinoma.
@nl
type
label
MicroRNA122 is a key regulator ...... s of hepatocellular carcinoma.
@en
MicroRNA122 is a key regulator ...... s of hepatocellular carcinoma.
@nl
prefLabel
MicroRNA122 is a key regulator ...... s of hepatocellular carcinoma.
@en
MicroRNA122 is a key regulator ...... s of hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
MicroRNA122 is a key regulator ...... ss of hepatocellular carcinoma
@en
P2093
Akemi Takata
Alain Nepveu
Charles Vadnais
Haruhiko Yoshida
Kentaro Kojima
Masao Akanuma
Masao Omata
Naoya Kato
Takahiro Kishikawa
Takeshi Yoshikawa
P2860
P2888
P356
10.1038/NCOMMS1345
P407
P577
2011-06-07T00:00:00Z